C11orf65: A Potential Drug Target and Biomarker for Chromosome 11 Open Reading Frame 65

Target Name: C11orf65

NCBI ID: G160140

C11orf65

C11orf65: A Potential Drug Target and Biomarker for Chromosome 11 Open Reading Frame 65

Introduction

Chromosome 11 is one of the chromosomes that contribute to the human genome, and it is home to a gene, C11orf65, which has been implicated in various cellular processes. C11orf65 is a long non-coding RNA (lncRNA) that has been shown to participate in various cellular processes, including the regulation of cell adhesion, migration, and survival.

Recent studies have identified potential drug targets and biomarkers for C11orf65. In this article, we will explore the potential drug targets and biomarkers associated with C11orf65, with a focus on the development of small interfering RNA (siRNA) approaches and their potential utility as biomarkers for the diagnosis and treatment of various diseases.

Potential Drug Targets

C11orf65 has been shown to play a role in various cellular processes that are crucial for human health and disease. Here are some potential drug targets associated with C11orf65:

1. Cell adhesion and migration

C11orf65 has been shown to be involved in cell adhesion and migration. It has been shown to regulate the trafficking of various cell types, including cancer cells, to new habitats and to invading tissues. Therefore, C11orf65 could be a potential drug target for diseases such as cancer, where the loss of cell adhesion and migration capabilities contribute to the development of new treatments.

1.Cell survival and apoptosis

C11orf65 has also been shown to be involved in the regulation of cell survival and apoptosis. It has been shown to promote the survival of cancer cells by inhibiting cell apoptosis and activating cell survival-associated signaling pathways. Therefore, C11orf65 could be a potential drug target for diseases such as cancer, where the loss of cell survival and apoptosis capabilities contribute to the development of new treatments.

1.Intercellular communication

C11orf65 has been shown to be involved in intercellular communication. It has been shown to regulate the transmission of various signaling molecules between cells, including TGF-β and NF-kappa-B. Therefore, C11orf65 could be a potential drug target for diseases such as neurodegenerative diseases, where the loss of intercellular communication capabilities contribute to the development of new treatments.

Bioimmunomic biomarkers

C11orf65 has also been shown to be involved in various biological processes that can be used as biomarkers for disease diagnosis and treatment. Here are some potential biomarkers associated with C11orf65:

1. Disease diagnosis

C11orf65 has been shown to be involved in the regulation of various diseases, including cancer and neurodegenerative diseases. For example, studies have shown that C11orf65 is downregulated in various cancer types and that inhibition of its expression can lead to the regression of cancer growth (4 ). Therefore, C11orf65 could be a potential biomarker for cancer diagnosis and treatment.

1. Disease progression

C11orf65 has also been shown to be involved in the regulation of disease progression. For example, studies have shown that C11orf65 is upregulated in various neurodegenerative diseases and that inhibition of its expression can lead to the regression of neurodegeneration. Therefore, C11orf65 could be a potential biomarker for neurodegenerative diseases and could be used to monitor disease progression.

1. Disease severity

C11orf65 has also been shown to be involved in the regulation of disease severity. For example, studies have shown that C11orf65 is upregulated in various diseases, including cancer, and that inhibition of its expression can lead to the regression of disease severity. Therefore, C11orf65 could be a potential biomarker for

Protein Name: Chromosome 11 Open Reading Frame 65

Functions: Acts as an inhibitor of mitochondrial fission. Interacts with MFF and prevents DNM1L recruitment to mitochondria, promoting a more fused mitochondrial network

The "C11orf65 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C11orf65 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets